Markus P Schlaich1, Omar Azzam2, Yusuke Sata2. 1. From the Dobney Hypertension Centre, School of Medicine (M.P.S., O.A.), Department of Cardiology (M.P.S.), and Department of Nephrology (M.P.S.), Royal Perth Hospital Unit, University of Western Australia; and Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia (M.P.S., Y.S.). markus.schlaich@uwa.edu.au. 2. From the Dobney Hypertension Centre, School of Medicine (M.P.S., O.A.), Department of Cardiology (M.P.S.), and Department of Nephrology (M.P.S.), Royal Perth Hospital Unit, University of Western Australia; and Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia (M.P.S., Y.S.).
Authors: Omar Azzam; Marcio G Kiuchi; Jan K Ho; Vance B Matthews; Leslie Marisol Lugo Gavidia; Janis M Nolde; Revathy Carnagarin; Markus P Schlaich Journal: Curr Hypertens Rep Date: 2019-09-10 Impact factor: 5.369